Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapy-Reference-Cited by-同舟云学术

Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapy

Published:2016-09 Issue: Volume:65 Page:33-42
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Dercle Laurent,Ammari Samy,Champiat Stéphane,Massard Christophe,Ferté Charles,Taihi Lokmane,Seban Romain-David,Aspeslagh Sandrine,Mahjoubi Linda,Kamsu-Kom Nyam,Robert Caroline,Marabelle Aurélien,Schlumberger Martin,Soria Jean-Charles,Postel-Vinay Sophie

Funder

Philanthropia Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

2. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N Engl J Med,2012

3. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma;Hamid;N Engl J Med,2013

4. Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial;Robert;Lancet,2014

5. Pseudoprogression and immune-related response in solid tumors;Chiou;J Clin Oncol,2015

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for severe immune‐related pneumonitis after nivolumab plus ipilimumab therapy for non‐small cell lung cancer;Thoracic Cancer;2024-06-03

2. Advances in Immunotherapy and Efficacy Prediction for Gastric Cancer;Advances in Clinical Medicine;2024

3. Evaluating Prognostic Value of Dynamics of Circulating Lactate Dehydrogenase in Colorectal Cancer Using Modeling and Machine Learning;Clinical Pharmacology & Therapeutics;2023-10-02

4. Associations of subcutaneous fat area and Systemic Immune-inflammation Index with survival in patients with advanced gastric cancer receiving dual PD-1 and HER2 blockade;Journal for ImmunoTherapy of Cancer;2023-06

5. Baseline Radiomic Signature to Estimate Overall Survival in Patients With NSCLC;Journal of Thoracic Oncology;2023-05